Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Skin Structure Infections (ABSSSI). Show all posts
Showing posts with label Skin Structure Infections (ABSSSI). Show all posts
Thursday, April 8, 2021

FDA Approves Kimyrsa (oritavancin) for the Treatment of Adult Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

›
Melinta Therapeutics, LLC (Melinta), a commercial-stage company focused on the development and commercialization of novel antibiotics, today...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.